Guest Editor
|
|
965
|
|
Full Article PDF
|
 |
|
Articles
|
Mouse models for breast cancer
|
966
|
Lothar Hennighausen
|
Abstract Full Article PDF
|
 |
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting
|
968
|
Robert D Cardiff, Miriam R Anver, Barry A Gusterson, Lothar Hennighausen, Roy A Jensen, Maria J Merino, Sabine Rehm, Jose Russo, Fattaneh A Tavassoli, Lalage M Wakefield, Jerrold M Ward & Jeffrey E Green
|
Abstract Full Article PDF
|
 |
The interactive web-based histology atlas system
|
989
|
Jai A Evans, Ulrike Wagner, Christopher M Santos & Lothar Hennighausen
|
Abstract Full Article PDF
|
 |
MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways
|
992
|
Robert Callahan & Gilbert H Smith
|
Abstract Full Article PDF
|
 |
Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer
|
1002
|
Yi Li, Wendy P Hively & Harold E Varmus
|
Abstract Full Article PDF
|
 |
WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis
|
1010
|
Minglin Li, Bernadette Lewis, Anthony V Capuco, Rodolfo Laucirica & Priscilla A Furth
|
Abstract Full Article PDF
|
 |
The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma
|
1020
|
Jeffrey E Green, Masa-Aki Shibata, Katsuhide Yoshidome, Min-ling Liu, Cheryl Jorcyk, Miriam R Anver, Jon Wigginton, Robert Wiltrout, Eiko Shibata, Stanislaw Kaczmarczyk, Weili Wang, Zi-yao Liu, Alfonso Calvo & Christine Couldrey
|
Abstract Full Article PDF
|
 |
A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland
|
1028
|
Christine Schulze-Garg, Jürgen Löhler, Andreas Gocht & Wolfgang Deppert
|
Abstract Full Article PDF
|
 |
Signal transduction in mammary tumorigenesis: a transgenic perspective
|
1038
|
David L Dankort & William J Muller
|
Abstract Full Article PDF
|
 |
Mutant p53 and genomic instability in a transgenic mouse model of breast cancer
|
1045
|
Kristen L Murphy & Jeffrey M Rosen
|
Abstract Full Article PDF
|
 |
A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development
|
1052
|
DJ Jerry, FS Kittrell, C Kuperwasser, R Laucirica, ES Dickinson, PJ Bonilla, JS Butel & D Medina
|
Abstract Full Article PDF
|
 |
Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation
|
1059
|
Chu-Xia Deng & Frank Scott
|
Abstract Full Article PDF
|
 |
Dual regulation of proliferation and apoptosis: c-myc in bitransgenic murine mammary tumor models
|
1065
|
M Hunter Jamerson, Michael D Johnson & Robert B Dickson
|
Abstract Full Article PDF
|
 |
The role of prolactin and growth hormone in breast cancer
|
1072
|
Håkan Wennbo & Jan Törnell
|
Abstract Full Article PDF
|
 |
Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth
|
1077
|
Archie J Vomachka, Scott L Pratt, Jason A Lockefeer & Nelson D Horseman
|
Abstract Full Article PDF
|
 |
Transforming growth factor alpha and mouse models of human breast cancer
|
1085
|
Robin C Humphreys & Lothar Hennighausen
|
Abstract Full Article PDF
|
 |
Transforming growth factor alpha- and c-myc-induced mammary carcinogenesis in transgenic mice
|
1092
|
Teresa A Rose-Hellekant & Eric P Sandgren
|
Abstract Full Article PDF
|
 |
Mammary gland oncogenes as indicators of pathways important in mammary gland development
|
1097
|
Clive Dickson, Anna Creer & Vera Fantl
|
Abstract Full Article PDF
|
 |
The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter
|
1102
|
Mark D Sternlicht, Mina J Bissell & Zena Werb
|
Abstract Full Article PDF
|
 |
Genetic determinants of response to chemotherapy in transgenic mouse mammary and salivary tumors
|
1114
|
DJ Bearss, MA Subler, JE Hundley, DA Troyer, RA Salinas & JJ Windle
|
Abstract Full Article PDF
|
 |
 |
 |